Kilitch Drugs starts production of Cephalosporin Injectables at Ethiopia Plant

Kilitch Drugs India Ltd. Leading manufacturer of Injectables in India starts production of the Cephalosporin Injectables at Ethiopia manufacturing plant. The Company had started its greenfield project in Ethiopia in 2018 to build a world-class Injectable plant.

In early 2021 the company has started production of Antiseptic and Disinfectant products to help Ethiopia fight against the COVID-19 pandemic.

For Cephalosporin Injectables plant is having total capacity of 26.4 million vials yearly while Ethiopia is having a demand for 16 million Vials. Through this plant most of the capacity is going to be sold in Ethiopia through Government & other institutes.

Commenting on this Mr. Mukund Mehta, Chairman & Managing Director of Kilitch Drugs said "Africa always has been our focus market for our products. We have started this manufacturing plant to cater to the African markets directly as there very few injectable manufacturing plants in whole continentand in turn help the people of Africa. Also, there is more demand than supply in the Ethiopia so we see that this has good business opportunity."

Shares of KILITCH DRUGS (INDIA) LTD. was last trading in BSE at Rs. 200.45 as compared to the previous close of Rs. 190.95. The total number of shares traded during the day was 35111 in over 382 trades.

The stock hit an intraday high of Rs. 200.45 and intraday low of 184. The net turnover during the day was Rs. 6945064.

Source : Equity Bulls

Keywords